Description
Additional file 3: Table S2. Pathway expression analysis of in vitro and in vivo enzalutamide-sensitive and –resistant prostate cancer samples. RNA sequencing data were retrieved from publically available datasets with accession numbers GSE55030, GSE109708, GSE184168, GSE163240, GSE150807 and GSE151083.
| Date made available | 29 Jul 2023 |
|---|---|
| Publisher | figshare |
Keywords
- Prostate cancer
- AR signalling blockade
- Enzalutamide
- GATA2-CDC6 axis
- Cellular senescene
Research output
- 1 Article
-
A GATA2-CDC6 axis modulates androgen receptor blockade-induced senescence in prostate cancer
Mourkioti, I., Polyzou, A., Veroutis, D., Theocharous, G., Lagopati, N., Gentile, E., Stravokefalou, V., Thanos, D.-F., Havaki, S., Kletsas, D., Panaretakis, T., Logothetis, C. J., Stellas, D., Petty, R., Blandino, G. (Lead / Corresponding author), Papaspyropoulos, A. (Lead / Corresponding author) & Gorgoulis, V. G. (Lead / Corresponding author), 29 Jul 2023, In: Journal of Experimental & Clinical Cancer Research. 42, 20 p., 187.Research output: Contribution to journal › Article › peer-review
Open AccessFile17 Link opens in a new tab Citations (Scopus)165 Downloads (Pure)
Cite this
- DataSetCite